minoxidil, lotion 2 g/100 ml
fagron nl b.v. venkelbaan 101 2908 ke capelle aan den ijssel - minoxidil 20 mg/ml - oplossing voor cutaan gebruik - bergamot oil (ri) ; denatoniumbenzoaat 1-water ; ethanol ; methylethylketon ; propyleenglycol (e 1520) ; water, gezuiverd, - minoxidil
hibiscrub, oplossing voor cutaan gebruik 40 mg/ml
mölnlycke health care ab gamlestadsvägen 3 c 415 02 gÖteborg (zweden) - chloorhexidinedigluconaat 40 mg/ml - oplossing voor cutaan gebruik - gluconolacton (e 575) ; glycerol (e 422) ; herbacol 015393 tdlyf ; isopropylalcohol ; lauryldimethylamine oxide ; macrogolglycerolcocoaat ; natriumhydroxide (e 524) ; poloxameer 237 ; ponceau 4r (e 124) ; water, gezuiverd, gluconolacton (e 575) ; glycerol (e 422) ; herbacol 15.393 t(b) ; isopropylalcohol ; lauryldimethylamine oxide ; macrogolglycerolcocoaat ; poloxameer 237 ; ponceau 4r (e 124) ; water, gezuiverd, - chlorhexidine
hibiscrub 40 mg/ml cut. opl.
mölnlycke health care ab se ab - chloorhexidinedigluconaat oplossing 0,2 ml - eq. chloorhexidinedigluconaat 40 mg - oplossing voor cutaan gebruik - 40 mg/ml - chloorhexidinedigluconaat 40 mg/ml - chlorhexidine
hibiscrub 40 mg/ml cut. opl. amp.
mölnlycke health care ab se ab - chloorhexidinedigluconaat oplossing 0,2 ml - eq. chloorhexidinedigluconaat 40 mg - oplossing voor cutaan gebruik - 40 mg/ml - chloorhexidinedigluconaat 40 mg/ml - chlorhexidine
antebor 10 % cut. opl.
kela pharma sa-nv - sulfacetamidenatrium 100 mg/ml - oplossing voor cutaan gebruik - 10 % - sulfacetamidenatrium 100 mg/ml - sulfacetamide
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromusculaire blokkade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromusculaire blokkade - alle andere therapeutische producten - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromusculaire blokkade - alle andere therapeutische producten - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromusculaire blokkade - alle andere therapeutische producten - omkering van neuromusculaire blokkade geïnduceerd door rocuronium of vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromusculaire blokkade - alle andere therapeutische producten - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.